Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2016-2027

  • Published Date : 22-09-2021
  • Pages : 84
  • Report Id : 56663
  • Categories : Healthcare

Summary

The global Chemotherapy-Induced Nausea and Vomiting Drugs market will reach xxx Million USD in 2021 with CAGR xx% 2021-2027. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa


Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Picture
1.1.2 Specifications
Table Product Specifications of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type, 2016-2027 (USD Million)
1.2.1.1 Existing Drugs
Table Existing Drugs Overview
1.2.1.2 Akynzeo (Netupitant-Palonosetron FDC)
Table Akynzeo (Netupitant-Palonosetron FDC) Overview
1.2.1.3 Aloxi (Palonosetron)
Table Aloxi (Palonosetron) Overview
1.2.1.4 Emend (Aprepitant)
Table Emend (Aprepitant) Overview
1.2.1.5 Kytril Generic (Granisetron)
Table Kytril Generic (Granisetron) Overview
1.2.1.6 Zofran Generic (Ondansetron)
Table Zofran Generic (Ondansetron) Overview
1.2.1.7 Pipeline Drugs
Table Pipeline Drugs Overview
1.2.1.8 SUSTOL (Granisetron Injection extended release)
Table SUSTOL (Granisetron Injection extended release) Overview
1.2.1.9 Rolapitant
Table Rolapitant Overview
1.2.2 by Application
Table Application Segment of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Application, 2016-2027 (USD Million)
1.2.2.1 Serotonin Receptor Antagonists
Table Serotonin Receptor Antagonists Overview
1.2.2.2 NK1 Receptor Antagonists
Table NK1 Receptor Antagonists Overview
1.2.3 by Regions
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region, 2016-2027 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
2.2 Upstream
Table Cost of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Manufacturing Process of Chemotherapy-Induced Nausea and Vomiting Drugs
2.3 Market
2.3.1 SWOT
Figure SWOT of Chemotherapy-Induced Nausea and Vomiting Drugs
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Chemotherapy-Induced Nausea and Vomiting Drugs
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Chemotherapy-Induced Nausea and Vomiting Drugs
3.4 Market Entry
Table Market Entry of Chemotherapy-Induced Nausea and Vomiting Drugs
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Existing Drugs Market, 2016-2020
Figure Existing Drugs Market Size and Growth, 2016-2020 (USD Million)
Figure Existing Drugs Market Size and Growth, 2016-2020 (in Volume)
Table Existing Drugs CAGR by Revenue and Volume, 2016-2020
4.1.2 Akynzeo (Netupitant-Palonosetron FDC) Market, 2016-2020
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Size and Growth, 2016-2020 (USD Million)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Size and Growth, 2016-2020 (in Volume)
Table Akynzeo (Netupitant-Palonosetron FDC) CAGR by Revenue and Volume, 2016-2020
4.1.3 Aloxi (Palonosetron) Market, 2016-2020
Figure Aloxi (Palonosetron) Market Size and Growth, 2016-2020 (USD Million)
Figure Aloxi (Palonosetron) Market Size and Growth, 2016-2020 (in Volume)
Table Aloxi (Palonosetron) CAGR by Revenue and Volume, 2016-2020
4.1.4 Emend (Aprepitant) Market, 2016-2020
Figure Emend (Aprepitant) Market Size and Growth, 2016-2020 (USD Million)
Figure Emend (Aprepitant) Market Size and Growth, 2016-2020 (in Volume)
Table Emend (Aprepitant) CAGR by Revenue and Volume, 2016-2020
4.1.5 Kytril Generic (Granisetron) Market, 2016-2020
Figure Kytril Generic (Granisetron) Market Size and Growth, 2016-2020 (USD Million)
Figure Kytril Generic (Granisetron) Market Size and Growth, 2016-2020 (in Volume)
Table Kytril Generic (Granisetron) CAGR by Revenue and Volume, 2016-2020
4.1.6 Zofran Generic (Ondansetron) Market, 2016-2020
Figure Zofran Generic (Ondansetron) Market Size and Growth, 2016-2020 (USD Million)
Figure Zofran Generic (Ondansetron) Market Size and Growth, 2016-2020 (in Volume)
Table Zofran Generic (Ondansetron) CAGR by Revenue and Volume, 2016-2020
4.1.7 Pipeline Drugs Market, 2016-2020
Figure Pipeline Drugs Market Size and Growth, 2016-2020 (USD Million)
Figure Pipeline Drugs Market Size and Growth, 2016-2020 (in Volume)
Table Pipeline Drugs CAGR by Revenue and Volume, 2016-2020
4.1.8 SUSTOL (Granisetron Injection extended release) Market, 2016-2020
Figure SUSTOL (Granisetron Injection extended release) Market Size and Growth, 2016-2020 (USD Million)
Figure SUSTOL (Granisetron Injection extended release) Market Size and Growth, 2016-2020 (in Volume)
Table SUSTOL (Granisetron Injection extended release) CAGR by Revenue and Volume, 2016-2020
4.1.9 Rolapitant Market, 2016-2020
Figure Rolapitant Market Size and Growth, 2016-2020 (USD Million)
Figure Rolapitant Market Size and Growth, 2016-2020 (in Volume)
Table Rolapitant CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Existing Drugs Market Forecast, 2021-2027
Figure Existing Drugs Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Existing Drugs Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Existing Drugs CAGR by Revenue and Volume, 2016-2027
4.2.2 Akynzeo (Netupitant-Palonosetron FDC) Market Forecast, 2021-2027
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Akynzeo (Netupitant-Palonosetron FDC) Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Akynzeo (Netupitant-Palonosetron FDC) CAGR by Revenue and Volume, 2016-2027
4.2.3 Aloxi (Palonosetron) Market Forecast, 2021-2027
Figure Aloxi (Palonosetron) Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Aloxi (Palonosetron) Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Aloxi (Palonosetron) CAGR by Revenue and Volume, 2016-2027
4.2.4 Emend (Aprepitant) Market Forecast, 2021-2027
Figure Emend (Aprepitant) Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Emend (Aprepitant) Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Emend (Aprepitant) CAGR by Revenue and Volume, 2016-2027
4.2.5 Kytril Generic (Granisetron) Market Forecast, 2021-2027
Figure Kytril Generic (Granisetron) Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Kytril Generic (Granisetron) Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Kytril Generic (Granisetron) CAGR by Revenue and Volume, 2016-2027
4.2.6 Zofran Generic (Ondansetron) Market Forecast, 2021-2027
Figure Zofran Generic (Ondansetron) Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Zofran Generic (Ondansetron) Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Zofran Generic (Ondansetron) CAGR by Revenue and Volume, 2016-2027
4.2.7 Pipeline Drugs Market Forecast, 2021-2027
Figure Pipeline Drugs Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Pipeline Drugs Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Pipeline Drugs CAGR by Revenue and Volume, 2016-2027
4.2.8 SUSTOL (Granisetron Injection extended release) Market Forecast, 2021-2027
Figure SUSTOL (Granisetron Injection extended release) Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure SUSTOL (Granisetron Injection extended release) Market Estimates and Forecasts, 2021-2027 (in Volume)
Table SUSTOL (Granisetron Injection extended release) CAGR by Revenue and Volume, 2016-2027
4.2.9 Rolapitant Market Forecast, 2021-2027
Figure Rolapitant Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Rolapitant Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Rolapitant CAGR by Revenue and Volume, 2016-2027
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Serotonin Receptor Antagonists Market, 2016-2020
Figure Serotonin Receptor Antagonists Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Serotonin Receptor Antagonists CAGR by Revenue and Volume, 2016-2020
5.1.2 NK1 Receptor Antagonists Market, 2016-2020
Figure NK1 Receptor Antagonists Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table NK1 Receptor Antagonists CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Serotonin Receptor Antagonists Market Forecast, 2021-2027
Figure Serotonin Receptor Antagonists Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Serotonin Receptor Antagonists Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Serotonin Receptor Antagonists CAGR by Revenue and Volume, 2021-2027
5.2.2 NK1 Receptor Antagonists Market Forecast, 2021-2027
Figure NK1 Receptor Antagonists Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure NK1 Receptor Antagonists Market Estimates and Forecasts, 2021-2027 (in Volume)
Table NK1 Receptor Antagonists CAGR by Revenue and Volume, 2021-2027
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2027
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2027
6.2.2 North America Market Forecast, 2021-2027
Figure North America Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2027 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2027
6.2.3 Europe Market Forecast, 2021-2027
Figure Europe Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2027
6.2.4 South America Market Forecast, 2021-2027
Figure South America Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2027 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2027
6.2.5 Middle East & Africa Market Forecast, 2021-2027
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2027 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2027 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2027
7 Market Competitive
7.1 Global Market by Vendors
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Vendors, 2016-2020 (in Volume)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Vendors, 2016-2020 (USD Million)
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Merck & Co., Inc.
Table Merck & Co., Inc. Profile List
Table Microecological Modulator Operating Data of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 GlaxoSmithKline plc
Table GlaxoSmithKline plc Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Tesaro, Inc.
Table Tesaro, Inc. Profile List
Table Microecological Modulator Operating Data of Tesaro, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Helsinn Group
Table Helsinn Group Profile List
Table Microecological Modulator Operating Data of Helsinn Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 F. Hoffmann-La Roche Ltd.
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Heron Therapeutics, Inc.
Table Heron Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of Heron Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Dr. Reddy's Laboratories Ltd.
Table Dr. Reddy's Laboratories Ltd. Profile List
Table Microecological Modulator Operating Data of Dr. Reddy's Laboratories Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Acacia Pharma
Table Acacia Pharma Profile List
Table Microecological Modulator Operating Data of Acacia Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Sun Pharmaceutical Industry Ltd.
Table Sun Pharmaceutical Industry Ltd. Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical Industry Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Otsuka Holdings Co., Ltd.
Table Otsuka Holdings Co., Ltd. Profile List
Table Microecological Modulator Operating Data of Otsuka Holdings Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2021 .